Stryker signed a definitive agreement to acquire Orthovita, a maker of orthobiologic and biosurgery products, for about $304 million in cash.
WSJ.com: US Business, Wall Street Journal: Business
Mon, 05/16/2011 - 6:23am
Stryker signed a definitive agreement to acquire Orthovita, a maker of orthobiologic and biosurgery products, for about $304 million in cash.